The Milwaukee-based firm is examining the specific terms of the acquisition by Viatris to determine if the board adequately fulfilled its fiduciary duties. Central to the inquiry are the substantial change-of-control payouts reserved for company insiders, which critics suggest may have influenced the negotiation process. Investigators are also scrutinizing the deal's restrictive clauses, particularly a significant termination penalty designed to deter competing bids.

Shareholders currently holding Pacira stock are being urged to review their rights, as the investigation seeks to uncover whether the $36.50 share price truly reflects the company's long-term market potential. Guri Ademi, representing the firm, is soliciting input from investors regarding the conduct of the board during the approval phase. The firm emphasizes that these consultations carry no cost or obligation for stakeholders involved in the potential litigation.